Who is more likely to adopt and comply with the electronic patient-reported outcome measure (ePROM) mobile application? A real-world study with cancer patients undergoing active treatment

• Published in: Supportive care in cancer Vol. 30; no. 1; pp. 659 - 668
• Main Authors: Lee, Mangyeong, Kang, Danbee, Kim, Sooyeon, Lim, Jihyun, Yoon, Junghee, Kim, Youngha, Shim, Sungkeun, Kang, Eunji, Ahn, Jin Seok, Cho, Juhee, Shin, Soo-Yong, Oh, Dongryul
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 2022; Springer; Springer Nature B.V
• Subjects: Cancer; Cancer patients; Cancer therapies; Care and treatment; Chemotherapy; Electronics; Humans; Medical centers; Medicine; Medicine & Public Health; Mobile Applications; Neoplasms - therapy; Nursing; Nursing Research; Oncology; Oncology, Experimental; Original Article; Pain Medicine; Patient compliance; Patient outcomes; Patient Reported Outcome Measures; Patients; Prospective Studies; Radiotherapy; Rehabilitation Medicine; Smart phones; Wireless telephone software; Symptom monitoring; Patient-reported outcomes; Mobile application; Compliance; Adoption; Real-world data
• ISSN: 0941-4355; 1433-7339
• DOI: 10.1007/s00520-021-06473-6

Purpose This study aims to identify factors associated with the adoption and compliance of electronic patient-reported outcome measure (ePROM) use among cancer patients in a real-world setting. Methods This prospective cohort study was conducted at the Samsung Medical Center in Seoul, Korea, from September 2018 to January 2019. Cancer patients aged 18 years or older who owned smartphones and who were receiving chemotherapy or radiation therapy were eligible for this study. Patients were asked to use the app to report their symptoms every 7 days for a total of 21 days (3 weeks). Logistic regression was performed to identify the factors associated with the adoption and compliance. Results Among 580 patients, 417 (71.9%) adopted the ePROM app and 159 (27.4%) out of 417 had good compliance. Patients who had greater expectations regarding the ease of use (adjusted odds ratio [aOR] 2.67, 95% CI: 1.28–5.57) and usefulness (aOR 1.69, 95% CI: 1.05–2.72) of the ePROM app were more likely to adopt the app than those who did not. Patients who had greater satisfaction with usefulness (aOR 1.89, 95% CI 1.10–3.25) were more likely to comply with using the app, but satisfaction with ease of use was not related to the compliance. Conclusion While expectation regarding the ease of use and usefulness of the ePROM app was associated with the adoption of the app, satisfaction with ease of use was not related to compliance with the ePROM app. Satisfaction with usefulness was associated with the compliance of ePROM app use.